United States · Venture startup

Who invested in Fate Therapeutics

6 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$86Mraised across 6 rounds since 2007, from 6 sources

$12MSeries A$1.0MDebt$36MSeries B$9.2MVenture$20MDebt$8.0MVenture
Latest round
Venture, $8.0MMay 2015
Biggest round
$36MSeries B · May 2011
Investors
6
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2009201120132015
$12MSeries A$1.0MDebt$36MSeries B$9.2MVenture$20MDebt$8.0MVenture
First round
Series A, $12M
Nov 2007
Biggest round
$36M
Series B · May 2011
Usual gap between rounds
21 months
the median of 4

The rounds

  1. May 2015
    Venture$8.0M

    No investor was named in the report.

    From a historical funding recordSEC filing: $8.0M sold, first sale May 2015

  2. Aug 2013
    Debt$20M

    No investor was named in the report.

    Reported by venturedeal.comSEC filing: $20M sold, first sale Aug 2013

  3. Aug 2012
    Venture$9.2M

    No investor was named in the report.

    Reported by nctimes.comSEC filing: $9.2M sold, first sale May 2012

  4. May 2011
    Series B$36M2 new4 returning

    Reported by sec.govSEC filing: $36M sold, first sale Nov 2009

  5. Apr 2011
    Debt$1.0M

    No investor was named in the report.

    Reported by sec.govSEC filing: $36M sold, first sale Nov 2009

  6. Nov 2007
    Series A$12M4 new

    Reported by seattle.bizjournals.com

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2007Debt2011Series B2011Venture2012Debt2013Venture2015VenrockPolaris PartnersARCH Venture PartnersOVP Venture PartnersAstellas Venture ManagementSanofi-Genzyme BioVentures

Everyone who backed them

VenrockVC firm2rounds
Polaris PartnersVC firm2rounds
ARCH Venture PartnersVC firm2rounds
OVP Venture PartnersVC firm2rounds
Astellas Venture ManagementCorporate VC1round
Sanofi-Genzyme BioVenturesCorporate VC1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Fate Therapeutics

Who invested in Fate Therapeutics?

Fate Therapeutics's investors include Venrock, Polaris Partners, ARCH Venture Partners, OVP Venture Partners and Astellas Venture Management, and 1 more on record.

How much has Fate Therapeutics raised?

Fate Therapeutics has raised $86M across 6 rounds since 2007.

When did Fate Therapeutics last raise?

Fate Therapeutics's most recent round was a Venture of $8.0M in May 2015.

What was Fate Therapeutics's biggest round?

Fate Therapeutics's largest round on record is $36M (Series B), in May 2011.

Who backed Fate Therapeutics first?

Fate Therapeutics's first round on record, in Nov 2007, was backed by Venrock, Polaris Partners and ARCH Venture Partners and 1 others.

What stage is Fate Therapeutics at?

Fate Therapeutics's latest named round is a Venture, in May 2015.

Where is Fate Therapeutics based?

Fate Therapeutics is based in the United States.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app